1. Home
  2. UFPT vs CPRX Comparison

UFPT vs CPRX Comparison

Compare UFPT & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UFPT
  • CPRX
  • Stock Information
  • Founded
  • UFPT 1963
  • CPRX 2002
  • Country
  • UFPT United States
  • CPRX United States
  • Employees
  • UFPT N/A
  • CPRX N/A
  • Industry
  • UFPT Medical/Dental Instruments
  • CPRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • UFPT Health Care
  • CPRX Health Care
  • Exchange
  • UFPT Nasdaq
  • CPRX Nasdaq
  • Market Cap
  • UFPT 2.4B
  • CPRX 2.5B
  • IPO Year
  • UFPT 1993
  • CPRX 2006
  • Fundamental
  • Price
  • UFPT $255.40
  • CPRX $22.47
  • Analyst Decision
  • UFPT Buy
  • CPRX Strong Buy
  • Analyst Count
  • UFPT 3
  • CPRX 7
  • Target Price
  • UFPT $323.50
  • CPRX $31.14
  • AVG Volume (30 Days)
  • UFPT 72.9K
  • CPRX 820.3K
  • Earning Date
  • UFPT 11-05-2024
  • CPRX 11-06-2024
  • Dividend Yield
  • UFPT N/A
  • CPRX N/A
  • EPS Growth
  • UFPT 29.17
  • CPRX 114.68
  • EPS
  • UFPT 6.99
  • CPRX 1.18
  • Revenue
  • UFPT $461,848,000.00
  • CPRX $460,482,000.00
  • Revenue This Year
  • UFPT $27.98
  • CPRX $23.98
  • Revenue Next Year
  • UFPT $18.23
  • CPRX $18.27
  • P/E Ratio
  • UFPT $36.24
  • CPRX $18.72
  • Revenue Growth
  • UFPT 18.48
  • CPRX 32.17
  • 52 Week Low
  • UFPT $152.43
  • CPRX $13.12
  • 52 Week High
  • UFPT $366.41
  • CPRX $24.27
  • Technical
  • Relative Strength Index (RSI)
  • UFPT 39.12
  • CPRX 54.94
  • Support Level
  • UFPT $232.02
  • CPRX $20.93
  • Resistance Level
  • UFPT $297.40
  • CPRX $22.49
  • Average True Range (ATR)
  • UFPT 14.15
  • CPRX 0.60
  • MACD
  • UFPT -4.68
  • CPRX 0.00
  • Stochastic Oscillator
  • UFPT 33.31
  • CPRX 77.06

About UFPT UFP Technologies Inc.

UFP Technologies Inc is a designer and custom manufacturer of components, subassemblies, products and packaging utilizing specialized foams, films, and plastics for the medical market. The company manufactures its products by converting raw materials using laminating, molding, radio frequency and impulse welding and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.

Share on Social Networks: